ACCESSION: MSBNK-SMB_Measured-HSA001P0153008
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 15
COMMENT: RAW_SPEC {'ProcedureBlank_8643': {'bp': 125684.0, 'sum': 288061.0}, '11_posi_8665': {'bp': 118780.0, 'sum': 240166.0}, '17_posi_8685': {'bp': 117310.0, 'sum': 265211.0}, '2_posi_8644': {'bp': 112822.0, 'sum': 239725.0}, 'BLK02_8665': {'bp': 109125.0, 'sum': 262658.0}, '1_posi_8667': {'bp': 104650.0, 'sum': 200565.0}, '19_posi_8705': {'bp': 103905.0, 'sum': 218325.0}, '6_posi_8623': {'bp': 103318.0, 'sum': 226172.0}, '17_posi_8811': {'bp': 91920.0, 'sum': 221373.0}, 'ProcedureBlank_8771': {'bp': 83970.0, 'sum': 187247.0}, '19_posi_8829': {'bp': 81795.0, 'sum': 175963.0}, '1_posi_8787': {'bp': 79774.0, 'sum': 179042.0}, '3_posi_8873': {'bp': 74278.0, 'sum': 181483.0}, '14_posi_8979': {'bp': 62977.0, 'sum': 151761.0}, '19_posi_9355': {'bp': 49049.0, 'sum': 143488.0}}
COMMENT: RETENTION_TIME_STDEV 0.379
COMMENT: PRECURSOR_M/Z_RAW 153.113085
COMMENT: PRECURSOR_M/Z_STDEV 0.000053
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.309; C7H12N4; [M+H]+; delta(ppm) -0.308995
COMMENT: PROPOSED_MF MS-FINDER 2.667; C7H12N4; [M+H]+; delta(ppm) -0.312476
COMMENT: PROPOSED_MF SIRIUS5_Sirius 10.389; C7H12N4; [M+H]+; delta(ppm) -0.312476
COMMENT: PROPOSED_MF SIRIUS5_Sirius 0.937; C9H14NO; [M+H]+; delta(ppm) -9.081472
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H12N4; [M+H]+; delta(ppm) -0.312476
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.470; C7H12N4; [M+H]+; delta(ppm) -0.312476
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.974; C9H14NO; [M+H]+; delta(ppm) -9.081472
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.516; C4H13FN4O; [M+H]+; delta(ppm) -7.775209
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.027; C3H15N5P; [M+H]+; delta(ppm) -2.331256
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H12N4; [M+H]+; delta(ppm) -0.312476
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.960; KYAGGLONXREQED-UHFFFAOYSA-N; [M+H]+; 3-ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.824; RWSWNQOCJVPCMF-UHFFFAOYSA-N; [M+H]+; 5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.566; RMTCWOLYVMOKBR-UHFFFAOYSA-N; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.531; SAYXVILDUZLWGX-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.297; FHYDQGOVTLQZSZ-UHFFFAOYSA-N; [M+H]+; N'-pyrimidin-2-ylpropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.227; MHMOUFDAKNJXSK-UHFFFAOYSA-N; [M+H]+; 1-(1H-imidazol-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.188; KFJYLCFNRATSPE-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.105; ASGQRNXDYZQNPS-UHFFFAOYSA-N; [M+H]+; 4-(triazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; DAAKLDCBWHWWNI-RMKNXTFCSA-N; [M+H]+; N-methyl-N-[(E)-(1-methylimidazol-2-yl)methylideneamino]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.934; QDEKQIPSPLAOPI-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.921; OQHDZWPNEOFLCW-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.908; SANLPMMCLNQJPP-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-5-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.893; YPPVPNFMCXRUCC-UHFFFAOYSA-N; [M+H]+; 4-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.883; GMVWRTAXMQPIBG-UHFFFAOYSA-N; [M+H]+; 5-(1-aminoethyl)-4-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.874; FILWPDPGRBPZDL-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.849; QFOSWZIUPHQBRK-UHFFFAOYSA-N; [M+H]+; 8-methyl-2,3,6,7-tetrahydroimidazo[1,2-a]pyrimidin-5-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.829; IMQGJTWGILNPMZ-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.804; JUYYERAJUGNAKT-UHFFFAOYSA-N; [M+H]+; 2-(3-cyclopropyl-1,2,4-triazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.799; JBICIOACIKMMJM-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-N,N-dimethylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.798; MSQSNZKVWZTSDJ-UHFFFAOYSA-N; [M+H]+; 2-(4-cyclopropyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.787; GFUMZGPBCAJZHH-UHFFFAOYSA-N; [M+H]+; 2-(4-cyclopropyltriazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.779; KHDBXRADZIIFBK-UHFFFAOYSA-N; [M+H]+; 2-(1-cyclopropyltriazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.776; GESFEOZCDXMGFO-UHFFFAOYSA-N; [M+H]+; 2-(6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.753; DLVUEWDMHXYYAO-UHFFFAOYSA-N; [M+H]+; 2-(3-cyclopropyl-1H-1,2,4-triazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.748; WJXSFSALUZCCJQ-UHFFFAOYSA-N; [M+H]+; 3,8-dimethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.738; KLDLJJRSWZYEFL-UHFFFAOYSA-N; [M+H]+; 6,6-dimethyl-4,5-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.736; LGIWBPLJDKOQSX-UHFFFAOYSA-N; [M+H]+; 4-(2H-triazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.731; KGXBEJFERUBKKY-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.724; ZEFRABOWIHXNKA-UHFFFAOYSA-N; [M+H]+; 3-methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-d][1,4]diazepine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.721; IFPQNVUJBNWAGL-UHFFFAOYSA-N; [M+H]+; 2-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.716; OIZMGVQEOVIMOL-UHFFFAOYSA-N; [M+H]+; 4-methyl-3-pyrrolidin-3-yl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.715; XNHWFJRPVBJRPR-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.714; KGLMRCGIKAKFCH-UHFFFAOYSA-N; [M+H]+; 3-(triazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.714; MJIWVLBPVFCYJB-ZETCQYMHSA-N; [M+H]+; 1-[[(2S)-pyrrolidin-2-yl]methyl]triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.712; BXSGLNRNBMUCIM-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.706; AGIXGQFDUZRXCT-UHFFFAOYSA-N; [M+H]+; 1-(pyrrolidin-2-ylmethyl)-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.704; QCAHQEGOYONBHI-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.704; NMHSRADHFBXGAG-UHFFFAOYSA-N; [M+H]+; 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.702; XDUNSNMMXUKPIN-ZCFIWIBFSA-N; [M+H]+; 4-methyl-3-[(2R)-pyrrolidin-2-yl]-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.696; KNGLSUWCXOCEKZ-UHFFFAOYSA-N; [M+H]+; 3-methyl-4,5,6,7-tetrahydrobenzotriazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.695; HSBDIERXOJWHKI-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.694; XMNCTKKZAFGKBV-UHFFFAOYSA-N; [M+H]+; 5-pyrrolidin-3-yl-1H-pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.693; FYKDYYGNYLGWCA-UHFFFAOYSA-N; [M+H]+; 2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.690; NNTDOOSCXNZOBK-UHFFFAOYSA-N; [M+H]+; 5-cyclopentyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.689; IZHAMQUVVWJULL-UHFFFAOYSA-N; [M+H]+; 3-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.684; PWQFWTMOGJDMLO-UHFFFAOYSA-N; [M+H]+; [3-(1,2,4-triazol-1-yl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.684; URSHNSSBVLGWNY-UHFFFAOYSA-N; [M+H]+; 1-methyl-4,5,6,7-tetrahydrobenzotriazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.681; YRQUFBNVMMTCEX-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.681; UOGYOJNDIFVZLJ-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.675; GREJTVKJTDGUQI-UHFFFAOYSA-N; [M+H]+; 2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.669; NYWMQSMKGVCQED-LURJTMIESA-N; [M+H]+; 3-methyl-5-[(2S)-pyrrolidin-2-yl]-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.654; FNMXKIOFMCGDMH-UHFFFAOYSA-N; [M+H]+; (5-cyclopropyl-2-methyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.639; COBJBBVQXYDCJU-UHFFFAOYSA-N; [M+H]+; N-[(1-methyltriazol-4-yl)methyl]cyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.635; KELKBKXPSNKQRJ-UHFFFAOYSA-N; [M+H]+; [1-(cyclopropylmethyl)triazol-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.627; OEURBUBEWIXBKU-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.622; DKRJNDYSGMPAAB-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.619; PWEGFMVXXGYUTH-UHFFFAOYSA-N; [M+H]+; 4-N-propan-2-ylpyrimidine-4,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.580; VFXLTLDREFAZCG-UHFFFAOYSA-N; [M+H]+; [3-(triazol-1-yl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.436; HWXAKUICDBKUDB-UHFFFAOYSA-N; [M+H]+; 4-azidobicyclo[2.2.1]heptan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.312; RMTCWOLYVMOKBR; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -159.141; PWEGFMVXXGYUTH; [M+H]+; 4-N-propan-2-ylpyrimidine-4,5-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.179; COBJBBVQXYDCJU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.102; RWSWNQOCJVPCMF; [M+H]+; 5-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -207.922; DKRJNDYSGMPAAB; [M+H]+; 1,2,4-triazolo[4,5-a]piperidin-3-ylmethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -248.545; NNTDOOSCXNZOBK; [M+H]+; 5-cyclopentyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.072; RMTCWOLYVMOKBR; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -62.770; ZWMZMTWLEKIUFQ; [M+H]+; N,4-diethyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -66.202; BKAURVRIEPTIAG; [M+H]+; N-ethyl-4,6-dimethyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -67.987; LNIIOZRGQWETJO; [M+H]+; 4-ethyl-N,6-dimethyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -76.055; LILLLWCWJKAPIQ; [M+H]+; N-[(2-methyl-1,2,4-triazol-3-yl)methyl]prop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -76.555; XABRIRPSIQOOTI; [M+H]+; 4,6-Diethyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -77.497; WPWUENJNSMKAEX; [M+H]+; 1-(4,6-Dimethyl-1,3,5-triazin-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -80.858; DYBSLYHZHMNTCA; [M+H]+; (1E,5E)-2,4-dimethyl-3-methylidene-7H-1,2,4,5-tetrazocine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.827; CNLTZOMMCPIQFF; [M+H]+; N-(2-aminoethylidene)-N'-[1-[(Z)-ethylideneamino]ethenyl]methanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.945; NXJISVQEQGMFRN; [M+H]+; N-[(1-methyl-1,2,4-triazol-3-yl)methyl]prop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -82.855; KVWYKBKEDPTBCY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.110; ZWMZMTWLEKIUFQ; [M+H]+; N,4-diethyl-1,3,5-triazin-2-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H13N4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 17.609
MS$FOCUSED_ION: PRECURSOR_M/Z 153.113425
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-2900000000-946f3f6b8bd7b4431aaa
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  71.0603975 260.9289 71.061011 0.5910 29.48 0.9107 15 f{C3H7N2}/0.32ppm,p-C4H6N2
  83.0603103 97.6418 83.060814 1.6614 24.35 0.4536 15 f{C4H7N2}/-0.77ppm,p-C3H6N2
  85.0759615 75.1208 85.076441 1.6691 20.17 0.6214 15 f{C4H9N2}/-0.74ppm,p-C3H4N2
  110.0713335 194.4666 110.071560 1.3355 41.12 0.6571 15 f{C5H8N3}/0.54ppm,p-C2H5N1
  124.0869740 45.7311 124.087029 3.2719 10.95 0.4273 11 f{C6H10N3}/0.41ppm,p-C1H3N1
  126.1025896 61.3606 126.102616 2.9103 12.24 0.6176 14 f{C6H12N3}/0.13ppm,p-C1H1N1
  153.1024249 87.4810 153.102321 1.8680 24.81 0.7000 15 ?
  153.1132529 999.0000 153.113149 0.6009 0.00 1.0000 15 f{C7H13N4}/-1.44ppm,p
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  71.060397 260.93 260
  83.060310 97.64 97
  85.075961 75.12 75
  110.071333 194.47 194
  124.086974 45.73 45
  126.102590 61.36 61
  153.102425 87.48 87
  153.113253 999.00 999
//
